Kenneth T. Mills, Director at REGENXBIO Inc. (RGNX), sold 2,410 shares at $13.76 ($33K) on 2024-07-16, disclosed to the SEC on 2024-07-18.
Scheduled sale ($33k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.76 | 200 | $3K | 8.3% |
| 2 | $13.77 | 2,210 | $30K | 91.7% |
| Total | $13.77 avg | 2,410 | $33K | 100% |
| Filing → |
| RGNX | SELL | 2024-05-16 | $237K | — | Filing → |
| RGNX | SELL | 2024-04-17 | $273K | — | Filing → |
| RGNX | SELL | 2024-03-18 | $328K | — | Filing → |